About Elevation Pharmaceuticals
Elevation Pharmaceuticals is a company based in San Diego (United States) founded in 2007 was acquired by Sunovion in August 2012. Elevation Pharmaceuticals has raised $77 million across 3 funding rounds from investors including TPG, Canaan and Sunovion. Elevation Pharmaceuticals offers products and services including Drug Pipeline and Clinical Trials. Elevation Pharmaceuticals operates in a competitive market with competitors including MediciNova, TFF Pharmaceuticals, Theravance Biopharma, Elastrin and Chance Pharmaceuticals, among others.
- Headquarter San Diego, United States
- SectorsHealthcare
- Website elevationpharma.com
- Social LinkedIn
- Acquired by Sunovion (Aug 2012)
- Legal Name Sunovion Pharmaceuticals Inc.
Products & Services of Elevation Pharmaceuticals
Elevation Pharmaceuticals offers a comprehensive portfolio of products and services, including Drug Pipeline and Clinical Trials.
Develops treatments for oncology and rare diseases
Conducts trials for innovative health therapies
Funding Insights of Elevation Pharmaceuticals
Elevation Pharmaceuticals has successfully raised a total of $77M across 3 strategic funding rounds. The most recent funding activity was a Series B round of $30 million completed in January 2012. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $77M
- Total Rounds 3
- Last Round Series B — $30M
- First Round $30M
(Jan 2010)
- Investors Count 5
All 3 funding rounds of Elevation Pharmaceuticals with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jan 2012 | $30M | Series B | – | – | |
| Sep 2011 | $17M | Series A | – | Canaan, Care Capital | – |
| Jan 2010 | $30M | Series A | – | Canaan, Care Capital | – |
6 investors in total: 6 institutional.
Investors in Elevation Pharmaceuticals
Elevation Pharmaceuticals has secured backing from 6 investors, including venture fund investors. Prominent investors backing the company include TPG, Canaan and Sunovion.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Canaan is recognized as an early-stage venture capital firm. | 1987 | canaan.com | San Francisco, United States | |
- | – | carecapital.com | - | |
- | – | mesaverdevp.com | - | |
Fund of funds focused on pre-seed and seed-stage companies | 1992 | tpg.com | Fort Worth, United States | |
Private equity and venture capital fund focused on the healthcare sector | – | novoholdings.dk | Hellerup, Denmark | |
Pharmaceutical company that specializes in treatment of CNS and respiratory ailments | 1984 | sunovion.com | Marlborough, United States |
Investor details for Elevation Pharmaceuticals
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Timeline of Elevation Pharmaceuticals
4 dated milestones of Elevation Pharmaceuticals across 5 years, from founding to its latest funding, stage changes and deals.
- Founded Elevation Pharmaceuticals is founded.
- Funding First funding round of $30.0M.
- Funding Latest funding round, Series B, of $30.0M.
- Exit Acquired by Sunovion.
Competitors of Elevation Pharmaceuticals
Elevation Pharmaceuticals operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as MediciNova, TFF Pharmaceuticals, Theravance Biopharma, Elastrin and Chance Pharmaceuticals, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| medicinova.com | 2000 | San Diego, United States | $83.94M | 13 | Small-molecule therapeutics are developed for asthma, COPD, and neurologic diseases. | |
| tffpharma.com | 2018 | Austin, United States | $22.17M | 15 | Developer of inhalation products for chronic respiratory diseases | |
| theravance.com | 2001 | Francisco, United States | – | 99 | Therapeutics for inflammatory and immunological diseases are developed. | |
| elastrin.com | 2017 | Simpsonville, United States | $17.25M | – | Developer of therapeutic targets related to arterial and lung diseases | |
| chancepharmaceuticals.com | 2015 | Hangzhou, China | $31.03M | – | Inhalation therapies for pulmonology disorders are developed. | |
| realtalifesciences.com | 2018 | Norfolk, United States | $81.5M | 19 | Therapeutic drugs for acute inflammatory and rare diseases are developed. | |
| zeoscientifix.com | 2011 | Fort Lauderdale, United States | $500,000 | – | Novel biological therapeutics are researched by the biopharmaceutical company. | |
| topigen.com | 2000 | Montreal, Canada | $50.09M | – | Respiratory disorder treatments are developed by this clinical-stage biopharmaceutical firm. |
Detailed competitors of Elevation Pharmaceuticals
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Elevation Pharmaceuticals
Complete news archive for Elevation Pharmaceuticals
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Similar companies to Elevation Pharmaceuticals
10 companies that operate in the same segment as Elevation Pharmaceuticals (Pulmonology), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Portable oxygen concentrators are supplied for respiratory therapy needs. | 2001 | Goleta, California, United States | USD 51.65 M | USD 348.67 M | 766 | |
Cancer detection diagnostics assays are developed and offered. | 2005 | Boulder, Colorado, United States | USD 200.16 M | USD 88.5 M | 273 | |
Therapeutic devices for nasal breathing improvement are developed. | 2011 | Sunnyvale, California, United States | USD 176.4 M | – | 66 | |
Non-invasive breath-based diagnostics for cancer and infectious diseases are developed. | 2004 | Cambridge, Cambridgeshire, United Kingdom | USD 166.55 M | – | 202 | |
Protein biologics are developed for treating rare diseases. | 2005 | San Diego, California, United States | USD 171.52 M | USD 190 K | 59 | |
Therapeutics for rare respiratory diseases are developed by Savara Pharma. | 2008 | Austin, Texas, United States | USD 67.82 M | – | 59 | |
Developer of smart devices for treating pulmonary diseases | 1998 | Redwood City, California, United States | USD 280.91 M | USD 90.5 M | 291 | |
A norovirus vaccine is developed for infection prevention. | 2021 | Boston, Massachusetts, United States | USD 135 M | – | 14 | |
Oral small molecule drugs for chronic diseases are developed. | 2017 | San Francisco, California, United States | USD 233 M | – | 163 | |
Precision medicines for lung-related diseases are developed. | 2015 | Menlo Park, California, United States | USD 371 M | – | – |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Elevation Pharmaceuticals
Elevation Pharmaceuticals was founded in 2007 and raised its 1st funding round 3 years after it was founded.
Elevation Pharmaceuticals is headquartered in San Diego, United States. It is registered at San Diego, California, United States.
Elevation Pharmaceuticals is a funded company, having raised a total of $77M across 3 funding rounds to date. The company's 1st funding round was a Series A of $30M, raised on Jan 2010.
Developer of aerosol drug products for COPD patients. Its lead clinical-stage product EP-101 is an inhalation solution of a long-acting muscarinic antagonist (LAMA) bronchodilator to treat COPD.
Elevation Pharmaceuticals's top competitors include TFF Pharmaceuticals, Theravance Biopharma and MediciNova.
Elevation Pharmaceuticals offers Drug Pipeline and Clinical Trials.
Elevation Pharmaceuticals operates through Sunovion Pharmaceuticals Inc..
Yes. Elevation Pharmaceuticals was acquired by Sunovion in August 2012.